Similar findings have been reported in oral SCC neoplasm [19] as well as breast carcinoma [14,16], ovarian carcinoma [11], and renal cell carcinoma [18], where reduced OVOL1 expression correlates with more aggressive and invasive phenotypes. Here, OVOL1 is linked to ovarian carcinoma.